ENTITY

SciSparc (SPRC US)

83
Analysis
Health Care • Israel
SciSparc Ltd. provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. SciSparc serves customers worldwide.
more
bullish•Dusit Thani
•08 Sep 2026 15:07•Broker

KTX Tactical Picks - September 8, 2026 (Eng.)

We recommend taking profit on IRPC after its holding-period return surged to +22.1%, and adding THANI to the portfolio as a replacement. Our...

Logo
92 Views
Share
•26 Jul 2024 10:12•Broker

Keep a Close Watch on US Inflation and Thai Corporate Earnings

Technically, the SET Index is expected to move sideways, with the support at 1,286/1,281 points and the resistance at 1,301/1,309 points (10-day...

Logo
90 Views
Share
•02 Sep 2026 10:38•Broker

Krungthai XSpring Zoom Eng. September 2, 2026

Global financial markets closed in risk-off mode after the 10-year US Treasury yield surged to 4.80%, its highest level in three years. Brent...

Logo
91 Views
Share
•26 Jan 2024 10:03•Broker

Technical Analysis

Most Asian bourses continued to advance thanks to China's economic stimulus while investors awaited the US GDP figure. The index was unable to run...

Logo
83 Views
Share
bearish•Macroeconomics
•06 Nov 2023 18:46•Broker

Monthly Report: November 2023: Outlook: To Fall Further (With Some Rebounds), With the Support at 1,350/1,320 Points and the Resistance at 1,400/1,420 Points

KTX expects the SET Index to fall further (with some rebounds), with the support at 1,350/1,320 points and the resistance at 1,400 1,420 points,...

Logo
89 Views
Share
x